Consumers deem cough-cold season ‘slightly worse’ than last year, survey shows
SCOTTSDALE, Ariz. More people felt the 2009-2010 cough-cold season was “about the same” or only “slightly worse” than the year prior, a recent national survey of 1,017 Americans sponsored by Matrixx Initiatives found.
A little less than half, 42%, characterized this past year’s season as about the same historically with regard to illness levels, and 21% suggested it was slightly worse in large part because of the H1N1 pandemic hype.
“While this year’s flu pandemic thankfully proved less severe than initially expected, it’s important to remember that preparation and early treatment are the best defenses against the common cold, which can strike year round,” stated Tim Tucker, immediate past president of the American Pharmacists Association. “Unlike most cold medications that just mask symptoms, zinc products … can reduce the duration of [a] cold if taken within the first 24 to 48 hours after the onset of symptoms.”
The perception of heightened illness rates may have been lacking this season, but almost everyone prepared for the worst this year, the survey found. The Zicam Cold & Flu Report revealed that 95% of people said they took proactive steps to stay healthy and combat cold and flu.
The top things people did to proactively prepare themselves to stay healthy this year included: frequent hand washing (85%); avoiding touching eyes, nose or mouth (46%); liberal use of antibacterial gel (34%); avoiding shaking hands during cold and flu season (31%); and frequently sterilizing commonly used items in the home and office (26%).
Consumers’ biggest concern about getting the flu or a cold was feeling lousy (36%), followed by getting others sick (19%).
Walmsley to lead GSK’s European consumer healthcare business
LONDON GlaxoSmithKline earlier this week named Emma Walmsley to the post of president, consumer healthcare Europe and president designate for its worldwide consumer healthcare business, effective May 1. Within two years, global leadership for the consumer healthcare business will pass to Walmsley from John Clarke, current president, worldwide consumer healthcare.
“Under [Clarke’s] leadership, consumer healthcare has become a key element in GSK’s strategy to deliver sustainable financial performance,” stated GSK CEO Andrew Witty. “[Walmsley’s] appointment comes at an important time as we seek to diversify and further grow this business. It is also continued evidence of our approach to maintain leadership excellence at GSK through proactive succession planning.”
Walmsley joins GSK from L’Oreal where she has been the leader of their consumer products business in China. Previously, Walmsley was based in New York where she had global responsibility for the mass-market Maybelline cosmetics business.
As president of GSK’s European consumer healthcare business, Walmsley will have operational responsibility for GSK’s European business and brands, succeeding Manfred Scheske.
OTC Perspectives names annual awards finalists
FLORHAM PARK, N.J. OTC Perspectives on Monday announced the finalists for the 2nd annual OTC National Advertising Awards. Brands among the finalist include Vicks, Pepcid, Pepto Bismol, Claritin, Triaminic, Durex, Robitussin and Zyrtec.
Awards will be presented during a reception at the OTC National Conference May 18 and 19 in Philadelphia.
“Delegates attending the OTC National Conference will determine the winners for Best Branded TV and Best Branded Print Campaign award,” announced Bob Ehrlich, CEO of DTC Perspectives, and OTC National Conference chairman. “Independent expert judging panels will determine award winners for the other categories.”
The OTC National Conference this year will include keynote addresses from Jeff Arnold, founder of WebMD and chairman of Sharecare; author Jan-Benedict Steenkamp; and Jim Joseph, president of Lippe Taylor Brand Communications.